甘精胰岛素联合阿卡波糖治疗初诊2型糖尿病的疗效观察

目的探讨首次诊断2型糖尿病患者应用甘精胰岛素联合阿卡波糖治疗的疗效。方法 54例初诊的2型糖尿病患者应用甘精胰岛素联合阿卡波糖治疗12周,比较治疗前后空腹血糖、餐后2 h血糖、糖化血红蛋白(HbA1c)及低血糖发生率。结果治疗12周后,所有患者空腹血糖、餐后2 h血糖及HbA1c均控制在比较理想的水平,低血糖发生率低,未见严重不良反应。结论对于初诊2型糖尿病患者,应用精胰岛素联合阿卡波糖治疗是一种安全有效的治疗方案。

Efficacy of insulin glargine combined with acarbose in the treatment of newly - diagnosed type 2 diabetes

Objective To discuss the efficacy of insulin glargine combined with acarbose in newly-diagnosed patients with type 2 diabetes.Methods Fifty-four newly-diagnosed patients with type 2 diabetes received insulin glargine combined with acarbose for 12 weeks.After treatment,the fasting blood glucose(FBG),postprandial 2 hours blood glucose(P2hBG),hemoglobin A1c(HbA1c) and the incidence rate of the hypoglycemia were compared.Results After treatment of 12 weeks,FBG,P2hBG and HbA1c were effectively controlled within acceptable levels in all patients.Meanwhile the incidence rate of the hypoglycemia was very lower.There were no obvious adverse reactions.Conclusion For the newly-diagnosed patients with type 2 diabetes,insulin glargine combined with acarbose is a safe and effective scheme.